4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Tactile Manipulation (TACMAN)
Date du début: 1 janv. 2014, Date de fin: 31 déc. 2016,
TACMAN addresses the key problem of developing an information processing and control technology enabling robot hands to exploit tactile sensitivity and thus become as dexterous as human hands. The current availability of the required technology now allows us to considerably advance in-hand manipulation. TACMAN's goal is to develop fundamentally new approaches which can replace manual labor under i ...
Voir le projet
5
Participants partenaires
TERMINÉ
What You Say Is What You Did (WYSIWYD)
Date du début: 1 janv. 2014, Date de fin: 31 déc. 2016,
The What You Say Is What You Did project (WYSIWYD) will create a new transparency in human robot interaction (HRI) by allowing robots to both understand their own actions and those of humans, and to interpret and communicate these in human compatible intentional terms expressed as a language-like communication channel we call WYSIWYD Robotese (WR). WYSIWYD will advance this critical communication ...
Voir le projet
7
Participants partenaires
TERMINÉ
Social Interaction Characteristics for Socially Accepted Robots (SICSAR)
Date du début: 15 sept. 2014, Date de fin: 13 nov. 2016,
"Why robotic research, despite its advances, has not yet lead to the widespread use of robots in operative contexts treatable through human-robot cooperation? The SICSAR project proposes that the main reason resides not in intrinsic technical difficulties, but in the limits of the diffused expectation that, to collaborate with humans, robots need to be almost ""perfect"" - faultless - in their act ...
Voir le projet
1
Participant partenaire
TERMINÉ
Systems biology of liver cancer: an integrative genomic-epigenomic approach (MODHEP)
Date du début: 1 janv. 2011, Date de fin: 30 juin 2016,
"Cancer is a complex disease involving multiple genetic and epigenetic events occurring, and influencing each other, over a long period of time. Understanding cancer, and ultimately developing effective targeted therapies, will therefore require that mutations and epigenetic alterations be systematically investigated during the multiple stages of disease development, from identifiable pre-neoplast ...
Voir le projet